MissionIR Articles

Strongbridge Biopharma plc (NASDAQ: SBBP) is a biopharmaceutical company focused on rare endocrine disorders and other rare diseases. The company is committed to the development, in-licensing, acquisition and eventual commercialization of complementary product candidates across…

Cellceutix Corp. (OTC: CTIX) has brought together leading figures in the health and science arenas to work toward the goal of developing innovative small molecule therapies for areas of unmet medical need, particularly infectious disease,…

At Oxford BioMedica plc (OTC: OXBDF), the mission is to build a valuable, profitable biopharmaceutical company through the successful development and commercialization of breakthrough gene and cell-based medicines that improve the lives of patients. The…

Bovie Medical Corp. (NYSE: BVX) is a maker of medical devices and supplies. The company is also the developer of J-Plasma, a patented, new plasma-based surgical product that has the potential to be a transformational…

Established in 2011, OncoSec Medical Incorporated (NASDAQ: ONCS) is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through its proprietary technology, the company means…

Parnell Pharmaceuticals Holdings Ltd. (NASDAQ: PARN) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions. Parnell currently markets five products for companion animals and production animals in 14…

Histogenics Corp. (NASDAQ: HSGX) is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics’ regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives…

RespireRx Pharmaceuticals, Inc. (OTC: CORX), formerly Cortex Pharmaceuticals, Inc., has multiple drug development programs targeted toward the treatment of brain-related breathing disorders, such as obstructive or central sleep apnea and drug-induced respiratory depression – areas…

Synthetic Biologics, Inc. (NYSE: SYN) is a clinical stage company developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. One of the company’s lead candidates in phase 2 development is SYN-004, which is…

Israel-based BioLineRx Ltd. (NASDAQ: BLRX) is a clinical-stage biopharmaceutical company committed to identifying, in-licensing and developing promising therapeutic candidates. The company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops…

Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) is an emerging drug development company focused on the discovery, development and commercialization of new drugs, formulations, and compounds that provide therapies for chronic inflammatory disease and neurologic disorders.…

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) is a late stage pharmaceutical company focused on developing and selling Locilex (pexiganan cream 0.8%), a potent and broad spectrum topical antibiotic peptide, for the treatment of mild and moderate…

TapImmune Inc. (OTC: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally…

TiGenix NV (NYSE: TIG) is a European cell therapy company with an advanced clinical stage pipeline of adult stem cell programs, and a commercialized product. The stem cell programs are based on proprietary validated platforms…

Mymetics Corp. (OTC: MYMX) is a Switzerland-based biotechnology company focused on the development of next-generation preventative vaccines for infectious diseases. The company’s vaccines are designed to induce protection against early transmission and infection. They focus…

RXi Pharmaceuticals Corp. (NASDAQ: RXII) is a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, addressing high-unmet medical needs. The company’s discovery and clinical development programs…

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a…

Actinium Pharmaceuticals, Inc. (NYSE: ANTM) is a biopharmaceutical company focused on the development of cancer drugs. The company’s product candidates are based on its patented technology, which combines the cancer targeting precision of monoclonal antibodies…

RepliCel Life Sciences Inc. (OTC: REPCF) is a regenerative medicine company focused on developing autologous cell therapies that address conditions caused by a deficit of healthy cells required for normal healing and function. The company’s…

SciClone Pharmaceuticals (NASDAQ: SCLN) is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. The company’s proprietary lead product,…

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is a clinical-stage biopharmaceutical company developing new treatments for cancer, as well as associated pain, inflammation and immune diseases. The company recently licensed multiple late-stage biosimilar and biobetter antibodies for…

Cytosorbents Corp. (NASDAQ: CTSO) is a critical care-focused immunotherapy company using blood purification to control severe inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses. CytoSorb®, the company’s flagship product,…